Literature DB >> 2950913

The role of bovine collagen in the treatment of acne scars.

C K Varnavides, R A Forster, W J Cunliffe.   

Abstract

Eighteen patients with a variety of depressed scars, predominantly as a result of acne, were treated with a purified bovine dermal collagen prepared as an injection (Zyderm I) for direct implantation into the scars. Both subjective and objective assessment showed encouraging results in those with soft and distensible scars. This method is, however, largely unsuitable for rigid, fibrotic or ice-pick scarring. Any improvement was usually apparent by the third treatment session. This is a safe, virtually painless, simple technique requiring no specialized equipment and has a high patient acceptability-but is expensive.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2950913     DOI: 10.1111/j.1365-2133.1987.tb05812.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  5 in total

1.  [Acne vulgaris].

Authors:  M Toscano; J Tousignant; G Panet-Raymond
Journal:  Can Fam Physician       Date:  1992-11       Impact factor: 3.275

2.  Comparison of Q-Switched 1064-nm Nd: YAG laser and fractional CO2 laser efficacies on improvement of atrophic facial acne scar.

Authors:  Ali Asilian; Elias Salimi; Gita Faghihi; Farideh Dehghani; Nabet Tajmirriahi; Sayed Mohsen Hosseini
Journal:  J Res Med Sci       Date:  2011-09       Impact factor: 1.852

Review 3.  A Comprehensive Review of Non-Energy-Based Treatments for Atrophic Acne Scarring.

Authors:  Curtis Tam; Jeffrey Khong; Kevin Tam; Ruslan Vasilev; Wesley Wu; Salar Hazany
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-03-14

Review 4.  Fillers for the improvement in acne scars.

Authors:  Uwe Wollina; Alberto Goldman
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-09-29

5.  Successful treatment of depressed, distensible acne scars using autologous fibroblasts: a multi-site, prospective, double blind, placebo-controlled clinical trial.

Authors:  Girish S Munavalli; Stacy Smith; John M Maslowski; Robert A Weiss
Journal:  Dermatol Surg       Date:  2013-04-08       Impact factor: 3.398

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.